rxstat › Drug prices › Infliximab

Infliximab (Renflexis, Remsima) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Nov 16, 2026

Also sold as: Renflexis, Remsima, Ixifi, Avsola

Infliximab 100 mg/vial powder for solution costs about $493.00 per billed unit (often a pen or vial) on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.

Infliximab has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABSKONNBNS
100 mg/vial Powder For Solution$493.00/unit$4.93/unit$493.00/unit$493.00/vial$493.00/unit
120 mg/ml Kit$474.51/unitbrand $646.57$474.51/unit$474.51/unit$474.51/autoinjector$474.51/unit
Plan coverageCoveredSpecial approvalCoveredSpecial approvalSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 7 products
  • Remsima Sc 120 mg/ml Kit · CHC
    DIN 02511584 · $474.51/unit · Covered
  • Remdantry 100 mg/vial Powder For Solution · CHC
    DIN 02419475 · $493.00/unit · Covered
  • Avsola 100 mg/vial Powder For Solution · AMG
    DIN 02496933 · $493.00/unit · Covered
  • Ixifi 100 mg/vial Powder For Solution · PFI
    DIN 02523191 · $493.00/unit · Covered
  • Renflexis 100 mg/vial Powder For Solution · SSB
    DIN 02470373 · $493.00/unit · Covered
  • Remsima Sc 120 mg/ml Kit · CHC
    DIN 02511576 · $646.57/unit · Not covered
  • Remicade 100 mg/vial Powder For Solution · JAI
    DIN 02244016 · $962.68/unit · Not covered
Saskatchewan: 6 products
  • Remdantry 100 mg/vial Powder For Solution · CEL
    DIN 02419475 · $4.93/unit · Special approval
  • Renflexis 100 mg/vial Powder For Solution · ORG
    DIN 02470373 · $4.93/unit · Special approval
  • Avsola 100 mg/vial Powder For Solution · AMG
    DIN 02496933 · $4.93/unit · Special approval
  • Ixifi 100 mg/vial Powder For Solution · PFI
    DIN 02523191 · $4.93/unit · Special approval
  • Remsima Sc 120 mg/ml Kit · CEL
    DIN 02511576 · $474.51/unit · Special approval
  • Remsima Sc 120 mg/ml Kit · CEL
    DIN 02511584 · $474.51/unit · Special approval
Ontario: 6 products
  • Remsima Sc 120 mg/ml Kit · Celltrion Healthcare Co. Ltd.
    DIN 02511584 · $474.51/unit · Covered
  • Remsima Sc 120 mg/ml Kit · Celltrion Healthcare Co. Ltd.
    DIN 02511576 · $474.51/unit · Covered
  • Remdantry 100 mg/vial Powder For Solution · Celltrion Inc.
    DIN 02419475 · $493.00/unit · Covered
  • Renflexis 100 mg/vial Powder For Solution · Samsung Bioepis Co. Ltd
    DIN 02470373 · $493.00/unit · Covered
  • Ixifi 100 mg/vial Powder For Solution · Pfizer Canada Inc.
    DIN 02523191 · $493.00/unit · Covered
  • Avsola 100 mg/vial Powder For Solution · Amgen Canada Inc.
    DIN 02496933 · $493.00/unit · Covered
New Brunswick: 4 products
  • Remsima Sc 120 mg/ml Kit · CLT
    DIN 02511584 · $474.51/autoinjector · Special approval
  • Renflexis 100 mg/vial Powder For Solution · ORG
    DIN 02470373 · $493.00/vial · Special approval
  • Avsola 100 mg/vial Powder For Solution · AGA
    DIN 02496933 · $493.00/vial · Special approval
  • Ixifi 100 mg/vial Powder For Solution · PFI
    DIN 02523191 · $493.00/vial · Special approval
Nova Scotia: 7 products
  • Remsima Sc 120 mg/ml Kit · CLT
    DIN 02511576 · $474.51/unit · Special approval
  • Remsima Sc 120 mg/ml Kit · CLT
    DIN 02511584 · $474.51/unit · Special approval
  • Renflexis 100 mg/vial Powder For Solution · ORG
    DIN 02470373 · $493.00/unit · Special approval
  • Avsola 100 mg/vial Powder For Solution · AGA
    DIN 02496933 · $493.00/unit · Special approval
  • Ixifi 100 mg/vial Powder For Solution · PFI
    DIN 02523191 · $493.00/unit · Special approval
  • Remicade 100 mg/vial Powder For Solution · JAN
    DIN 02244016 · no listed price · Not covered
  • Remdantry 100 mg/vial Powder For Solution · HOS
    DIN 02419475 · no listed price · Not covered

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

No shortage or discontinuation reports have been filed with Health Canada for Infliximab. rxstat watches those reports through the day; sign up below to hear if that changes.

Common questions

How much does Infliximab cost in Canada?

Infliximab 100 mg/vial powder for solution costs about $493.00 per billed unit (often a pen or vial) on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.

Is Infliximab covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (immunosuppressants)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.